Get the Stockscreener App
10.27
1.63%
-0.17
Pre-market:
10.48
0.21
+2.04%
Kura Oncology Inc stock is traded at $10.27, with a volume of 1.67M.
It is down -1.63% in the last 24 hours and up +16.05% over the past month.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
See More
Previous Close:
$10.44
Open:
$10.48
24h Volume:
1.67M
Relative Volume:
0.91
Market Cap:
$891.41M
Revenue:
-
Net Income/Loss:
$-168.09M
P/E Ratio:
-4.7327
EPS:
-2.17
Net Cash Flow:
$-138.01M
1W Performance:
+5.88%
1M Performance:
+16.05%
6M Performance:
+56.55%
1Y Performance:
-38.58%
1-Day Range:
$10.00
$10.62
1-Week Range:
$9.80
$11.05
52-Week Range:
$5.41
$19.73
Kura Oncology Inc Stock (KURA) Company Profile
Name
Kura Oncology Inc
Sector
Industry
Phone
(858) 500-8800
Address
12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO, CA
Compare KURA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KURA
Kura Oncology Inc
|
10.27 | 906.16M | 0 | -168.09M | -138.01M | -2.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Kura Oncology Inc Stock (KURA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-04-25 | Initiated | Guggenheim | Neutral |
| Feb-06-25 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-24-24 | Initiated | UBS | Buy |
| Oct-14-24 | Downgrade | Stifel | Buy → Hold |
| Dec-22-23 | Initiated | Mizuho | Buy |
| Aug-11-23 | Initiated | BofA Securities | Buy |
| Jul-27-23 | Initiated | Scotiabank | Sector Perform |
| May-17-23 | Initiated | BTIG Research | Buy |
| Jan-31-23 | Initiated | Stifel | Buy |
| Jul-12-22 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-15-22 | Initiated | Jefferies | Buy |
| May-05-21 | Resumed | Credit Suisse | Outperform |
| Apr-26-21 | Resumed | Credit Suisse | Outperform |
| Dec-07-20 | Reiterated | H.C. Wainwright | Buy |
| Dec-03-20 | Initiated | Stifel | Buy |
| Nov-05-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-07-20 | Initiated | Credit Suisse | Outperform |
| May-05-20 | Initiated | Barclays | Overweight |
| Jul-18-19 | Initiated | Deutsche Bank | Buy |
| Nov-09-18 | Initiated | Piper Jaffray | Overweight |
| Aug-01-18 | Initiated | H.C. Wainwright | Buy |
| Oct-13-16 | Resumed | Leerink Partners | Outperform |
| Jan-22-16 | Initiated | JMP Securities | Mkt Outperform |
| Dec-30-15 | Initiated | Oppenheimer | Outperform |
| Dec-16-15 | Initiated | Citigroup | Buy |
View All
Kura Oncology Inc Stock (KURA) Latest News
Applying sector rotation models to Kura Oncology Inc.July 2025 Movers & Safe Capital Growth Tips - newser.com
Understanding Kura Oncology Inc.’s price movement2025 Market WrapUp & Daily Profit Maximizing Trade Tips - newser.com
Kura Oncology's Ziftomenib Poised For Differentiation (NASDAQ:KURA) - Seeking Alpha
What drives Kura Oncology Inc stock priceGap Up/Gap Down Analysis & Tap Into the Fastest-Growing Companies - earlytimes.in
Signal strength of Kura Oncology Inc. stock in tech scannersPortfolio Growth Summary & Weekly Sector Rotation Insights - newser.com
How Kura Oncology Inc. stock reacts to Fed rate cutsJuly 2025 Sector Moves & Short-Term High Return Ideas - newser.com
What analysts say about Kura Oncology Inc stockGap Up/Gap Down Analysis & Follow Top Performers in the Community - earlytimes.in
Can technical indicators confirm Kura Oncology Inc.’s reversalJuly 2025 Rallies & Target Return Focused Stock Picks - newser.com
What momentum indicators show for Kura Oncology Inc. stockAnalyst Downgrade & Safe Capital Preservation Plans - newser.com
Can Kura Oncology Inc. stock resist market sell offs2025 Retail Activity & Weekly High Return Stock Opportunities - newser.com
Kura Oncology (KURA) to Release Earnings on Thursday - MarketBeat
Kura Oncology Inc. stock momentum explained2025 Price Targets & Low Risk Entry Point Tips - newser.com
Candlestick signals on Kura Oncology Inc. stock todayJuly 2025 Weekly Recap & Verified Momentum Stock Ideas - newser.com
Why Kura Oncology Inc. stock attracts high net worth investorsPortfolio Risk Summary & Safe Swing Trade Setup Alerts - newser.com
Can Kura Oncology Inc. stock rebound after recent weaknessJuly 2025 Short Interest & Capital Efficiency Focused Strategies - newser.com
Is Kura Oncology Inc. showing signs of accumulation2025 Top Gainers & Trade Opportunity Analysis - newser.com
Kura Oncology’s KO-2806 Study: A New Hope for Advanced Solid Tumors? - The Globe and Mail
Kura Oncology (NASDAQ:KURA) Shares Up 9.1%Still a Buy? - MarketBeat
Kura Oncology to Report Third Quarter 2025 Financial Results - The Manila Times
Kura Oncology Inc Stock (KURA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):